Introduction
Over the past decade there has been a steady increase in the applicaion of particle accelerators to industrial processes and medicine. Accelerators have found greater utility in the manufacture of semiconductors radiopharmaceuticals, sterilization procedures, and in the treatment of malignant diseases. Under the Radiation Control for Health and Safety Act of 1968 (Public Law 90-602), accelerators are considered as ilectronic products and subject to the provisions of the Act . Although the provisions of the Act give the Secretary, Department of Health and Human Services (formerly Department of Health, Education and Welfare), authoritv to establish, among other things, performance standards for electronic products, no performance standards for accelerators have been developed under this Act. However, Section 359 of the Act addresses defects which relate to the safety of use of electron products by reason of the emission of electronic product radiation (i.e. any ionizing or nonionizing electromagnetic or particulate radiation, or any sonic, infrasonic, or ultrasonic wave, which is emitted from an electronic product as a result of the operation of an electronic circuit in such product). Part states that an electronic product shall be considered to have a defect which relates to the safety of use by reason of the emission of electronic product radiation if it is a product which utilizes electronic product radiation to accomplish its primary purpose and from which such emissions are intended, and as a result of its design, production or assembly it (1) fails to conform to its design specifications relating to the emission of electronic product radiation; or (2) without regard to the design specifications of the product, emits electronic product radiation unnecessary to the accomplishment of its primary purpose which creates a risk of injury, including genetic injury to any person; or (3) fails to accomplish the intended purpose. Thus, based on the defect provision, the specifications for radiation emission stipulated by the manufacturer relative to the safety of use, may constitute, in essence, a performance standard to which the device must conform.
In the absence of U.S. citation, a comparison of the recommended permissible levels of leakage radiation, in each citation, to the patient area, to the area outside the patient area, and through the beam limiting device.
Leakage Radiation to the Patient Area

NCRP Recommendations
The NCRP defines leakage radiation as all radiation coming from within the source housing except the useful beam. The NCRP recommendation that is applied to the leakage performance for accelerators is based on leakage from the protective source housing for sealed gamma ray sources. It does not distinguish between leakage radiation to the patient area and that outside the patient area. Section 4.2.1(b) of NCRP Report 33 states that for the protective source housing, beam "ON" position, the leakage radiation measured at one meter from the source shall not exceed 0.1 per cent of the useful beam exposure rate at that distance when the beam control mechanism is in the "ON" position, except for the portion of the housing which includes the collimator zone (see Figure 1 ). The IEC defines leakage radiation as ionizing radiation emerging after transmission through the protective radiation shielding of the radiation source. These recommendations use the International System (SI) of Units of which the "gray" is the unit of absorbed dose.
In reference to the patient area, paragraph 6.2 states that in a plane circular surface of radius 2 meters centered on and perpendicular to the axis of the beam at the normal treatment distance and outside the area of the maximum useful beam, the absorbed dose due to leakage radiation The proposed Canadian regulation does not define leakage radiation.
Although "dose" is not specifically defined, the SI unit of "gray" and the old unit "rad" are used throughout the proposed regulation. (manufactured after 1/1/85) and old equipment. F.9(b) (1) states that for leakage radiation to the patient area, new equipment must operate in such a manner that for operating conditions producing maximum leakage radiation, the abosrbed dose in rads due to leakage radiation, including xrays, electrons, and neutrons, at any point in a circular plane of 2 meters radius centered on and perpendicular to the central axis of the beam at the isocenter or normal treatment distance and outside the maximum useful beam size shall not exceed 0.1% of the maximum absorbed dose in rads of the unattenuated useful beam measured at the point of intersection of the central axis of the beam and the plane surface (see Figure 2) . For existing equipment the requirement is the same except that the leakage radiation excludes neutron radiation.
Neutron Leakage -Paragraph 6.3 states that except in the plane circular surface of 2 meters radius mentioned previously, the absorbed dose (Gy) due to neutron radiation measured at 1 meter from the path of the electrons between the electron gun and the target or electron window shall not exceed 0.05% of the maximum absorbed dose (Gy) on the axis of the beam at the normal treatment distance (see Figure 5 ).
Proposed Canadian Regulation
Paragraph g of Section 19 states that at any accessible point located at a distance of 1 meter from the virtual x-ray source or the path of the electron beam within the accelerator structure, the dose rates due to leakage radiation outside the maximum treatment beam, excluding neutrons, from the parts of the accelerator that are located within the treatment room, do not exceed the following percentages of the peak absorbed dose rate measured along the beam axis at 1 meter from the virtual xray source (see Figure 6 ). 
4-QPf Recommendations
As stated previously, the NCRP makes no distinction between leakage radiation to the patient area and outside the patient area.
Paragraph 6.2 of the IEC standard states that except in the plane circular surface of 2 meter radius centered on and perpendicular to the axis of the beam at the normal treatment distance, the absorbed dose (Gy) due to leakage radiation (excluding neutron radiation) at 1 meter from the path of the electrons between the electron gun and the target or electron window shall not exceed 0.5% of the maximum absorbed dose (Gy) on the axis of the beam at the normal treatment distance (see Figure 5) . Regulations states that for new equipment the absorbed dose in rads due to x-ray leakage radiation at any point 1 meter from the path of the charged particle before the charged particle strikes the target or window, except in the circular plan of 2 meter radius mentioned previously, shall not exceed 0.1% of the maximum absorbed dose in rads of the unattenuated useful beam measured at the point of intersection of the central axis of the beam and the circular plan (see Figure 5 ).
For new equipment, the absorbed dose in rads due to neutron leakage radiation at any point 1 meter from the path of the charged particle before the charged particle strikes the target or window, except in the circular plan of 2 meter radius mentioned previously, shall not exceed 0.05% of the maximum absorbed dose in rads of the unattenuated useful beam measured at the point of intersection of the central axis of the beam and the circular plane (see Figure 5 ).
For existing equipment, the requirement for x-ray leakage radiation is the same as for new equipment, however, requirements for neutron leakage radiation are excluded.
Leakage Radiation Through Beam Limiting Devices NCRP Recommendations Paragraph 4.2.1(c) of NCRP Report 33 states the beam defining apparatus comprising the collimator zone shall be constructed to attenuate the useful beam so that the transmitted exposure rate is not more than 5% of the unattenuated beam (see Figure 7) . For equipment 'i? which the maximum geometrical field size exceeds 500 cm at the normal treatment distance, the following additional limits shall apply.
For square fields of any size, the product of the average absorbed dose (Gy) due to leakage radiation through the beam limiting devices and the area shielded by the beam limiting devices shall not exceed 0.10 of the product of the maximum absorbed dose (Gy) on the axis of the beam and the area of the useful beam for a 10 cm x 10 cm field size (see Figure 9 ). Figure 9 ). 
